Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyvox for extensively drug-resistant pulmonary tuberculosis
NCT00727844Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2008
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linezolid in pulmonary tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2008; status: completed.
02
Drugs
linezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00727844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00727844.